4 Healthcare Stock Stories for Tuesday Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Hyperion Therapeutics (HPTX) Closing price $19.07

The firm reports that the FDA has okayed Ravicti for the treatment of urea cycle disorders  in patients two years of age and older. The medication should be commercially available by the end of April.


Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business